Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13151
InMed Pharmaceuticals
INM
$7.03M
| $40.4K | ﹤0.01% |
26,084
-20,889
| -44% | -$23.1K |
|
|
OSRH
13152
DELISTED
OSR Health
OSRH
| $40.4K | ﹤0.01% |
+127,810
| New | +$64.1K |
|
13153
Wearable Devices
WLDS
$3.89M
| $40.4K | ﹤0.01% |
+24,471
| New | +$74K |
|
13154
CALL
Diana Shipping
DSX
$372M
| $40.3K | ﹤0.01% |
19,200
-1,900
| -9% | -$4.69K |
|
13155
Austin Gold Corp
AUST
$15.9M
| $40.2K | ﹤0.01% |
+36,242
| New | +$48.5K |
|
13156
PUT
OFS Capital
OFS
$53.6M
| $40K | ﹤0.01% |
+11,300
| New | +$41.4K |
|
|
CMRC
13157
CALL
Commerce.com Inc Series 1
CMRC
$297M
| $40K | ﹤0.01% |
13,500
-25,000
| -65% | -$71.6K |
|
|
LHAI
13158
Linkhome Holdings
LHAI
$17.7M
| $39.9K | ﹤0.01% |
+60,401
| New | +$59.5K |
|
13159
UTStarcom
UTSI
$21.6M
| $39.8K | ﹤0.01% |
+15,980
| New | +$41.4K |
|
13160
Revelation Biosciences
REVB
$3.63M
| $39.7K | ﹤0.01% |
+38,579
| New | +$41.9K |
|
13161
CLPS Inc
CLPS
$30.1M
| $39.6K | ﹤0.01% |
+46,893
| New | +$43.5K |
|
13162
PUT
Lufax Holding
LU
$1.05B
| $39.5K | ﹤0.01% |
29,900
+14,100
| +89% | +$24K |
|
13163
Waldencast
WALD
$144M
| $39.5K | ﹤0.01% |
+22,425
| New | +$30K |
|
13164
PUT
Zevia
ZVIA
$93.8M
| $39.4K | ﹤0.01% |
+24,200
| New | +$32.9K |
|
13165
PRF Technologies Ltd
PRFX
$3.15M
| $39.4K | ﹤0.01% |
28,575
+15,355
| +116% | +$29.6K |
|
13166
60 Degrees Pharmaceuticals
SXTP
$2.98M
| $39.4K | ﹤0.01% |
+22,362
| New | +$36K |
|
13167
My Size
MYSZ
$1.56M
| $39.3K | ﹤0.01% |
10,915
+8,487
| +350% | +$37.7K |
|
13168
Quantum-Si Incorporated
QSI
$158M
| $39.2K | ﹤0.01% |
44,335
+28,789
| +185% | +$27.4K |
|
|
RYET
13169
Ruanyun Edai Technology Inc
RYET
$28.2M
| $39K | ﹤0.01% |
+37,503
| New | +$38.9K |
|
13170
Incannex Healthcare
IXHL
$41.3M
| $38.9K | ﹤0.01% |
+10,349
| New | +$37.8K |
|
13171
Lucid Diagnostics
LUCD
$152M
| $38.9K | ﹤0.01% |
+36,362
| New | +$39.2K |
|
|
VBIO
13172
Valion Bio
VBIO
$1.87M
| $38.5K | ﹤0.01% |
+2,966
| New | +$64.5K |
|
13173
Innoviz Technologies
INVZ
$90.4M
| $38.4K | ﹤0.01% |
50,410
-758,697
| -94% | -$519K |
|
|
13174
PUT
Diana Shipping
DSX
$372M
| $38.2K | ﹤0.01% |
+18,200
| New | +$44.9K |
|
|
FURY
13175
Fury Gold Mines
FURY
$106M
| $38.2K | ﹤0.01% |
70,744
-298,177
| -81% | -$171K |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.